This clinical tool assists medical professionals in rapidly determining lung cancer staging using the latest 9th Edition TNM Classification. It offers an intuitive interface for inputting patient data and provides instant, evidence-based stage calculations for informed decision-making at the point of care.
1.0
November 5, 2025
Lung Cancer Staging v9 is a clinical tool designed for medical professionals to rapidly determine lung cancer staging using the 9th Edition TNM Classification. It aids in making evidence-based decisions at the point of care.
The app is intended for physicians, surgeons, oncologists, pulmonologists, radiologists, physician assistants, nurse practitioners, and other advanced practitioners who manage lung cancer patients.
Lung Cancer Staging v9 utilizes the latest 9th Edition TNM Classification for accurate staging of non-small cell and small cell lung cancers.
The app features an intuitive input flow where users enter tumor size, lymph node involvement, and metastasis data. It then automatically generates the accurate stage with clear explanations based on the 9th Edition TNM Classification.
Yes, the app is built from published source material, ensuring reliability and accuracy for clinical decision-making. It is designed for point-of-care use, supporting evidence-based practice.
Lung Cancer Staging v9 is currently supported on iPhone and iPod devices, as indicated by the provided data.
Lung Cancer Staging v9 is a paid application, priced at $0.99. There are no in-app purchases or advertisements mentioned.
No, Lung Cancer Staging v9 does not contain advertisements. The app is ad-free, providing an uninterrupted experience for medical professionals.
